Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations
    • ADMINISTRATION OF MEDICARE/MEDICAID PROGRAMS—D. Kan.: Hospice provider’s challenge to Medicare enrollment revocation dismissed for lack of jurisdiction
    • BILLING AND CODING—2d Cir.: No Surprises Act does not provide implied private cause of action
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • CLINICAL RESEARCH—PROPOSED RULES: FDA proposes to replace animal testing references with broader nonclinical testing terminology
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • CONTROLLED SUBSTANCES—NOTICES: DEA revokes Puerto Rico physician’s registration following healthcare fraud exclusion
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • CONTROLLED SUBSTANCES—PROPOSED RULES: DEA proposes Schedule I controls for five tryptamine hallucinogens
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • COVERAGE—S.D. Fla.: HHS decision on prior authorization requirement reversed
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • DRUGS AND BIOLOGICS—NOTICES: FDA extends pilot to speed manufacturing readiness for expedited therapies
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • ENFORCEMENT ACTIONS—SETTLEMENT AGREEMENTS: OCR settles HIPAA investigation of Ambry Genetics phishing attack
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • FRAUD AND ABUSE—N.D. Tex.: Evidence insufficient to show unlawful intent by lab owner to influence physicians
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • GENERAL HEALTH CARE NEWS—GAO REPORTS: HHS only partially implemented defined oversight activities related to cybersecurity for 988 Lifeline in its network agreements
      • You have 1 more complimentary views available this month. Log in if you are already a customer
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations

    Health Law Daily Wrap Up, CONTROLLED SUBSTANCES—PROPOSED RULES: DEA proposes Schedule I controls for five tryptamine hallucinogens, (Sep 24, 2026)

    By WK Editorial Staff

    The DEA cited law enforcement encounters, poison center exposure reports, and similarities to already controlled hallucinogens in proposing Schedule I status for five synthetic tryptamines that are currently unapproved for medical use in the United S ...

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use